Complex patterns of altered microRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer

Clinical Cancer Research

Volumn 17, Issue 23, 2011, Pages 7283-7293

  Bartley, Angela N ^a   Yao, Hui ^a   Barkoh, Bedia A ^a   Ivan, Cristina ^a   Mishra, Bal M ^a   Rashid, Asif ^a   Calin, George A ^a   Luthra, Rajyalakshmi ^a   Hamilton, Stanley R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIN D1; FRIZZLED PROTEIN; MICRORNA; PHOSPHOLIPASE C BETA1; WNT PROTEIN;

ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; GASTROINTESTINAL DYSPLASIA; GASTROINTESTINAL MUCOSA; GENE EXPRESSION; GENE TARGETING; GENETIC REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; MICROSATELLITE MARKER; NUCLEAR LOCALIZATION SIGNAL; PRECURSOR; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADENOMA; BETA CATENIN; COLON; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; MICROSATELLITE REPEATS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECTUM; TUMOR MARKERS, BIOLOGICAL; WNT SIGNALING PATHWAY;

EID: 82555189387     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-1452     Document Type: Article

References (51)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008;135:1079-99.
3. George B, Kopetz S. Predictive and prognostic markers in colorectal cancer. Curr Oncol Rep 2011;13:206-15.
4. Hureta S. Recent advances in the molecular diagnosis and prognosis of colorectal cancer. Expert Rev Mol Diagn 2008;8:277-88.
5. Samowitz WS. Genetic and epigenetic changes in colon cancer. Exp Molec Pathol 2008;85:64-7.
6. Markowitz S, Bertagnolli M. Molecular basis of colorectal cancer. N Eng J Med 2009;361:2449-60.
7. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006;6:259-69.
8. Luo X, Burwinkel B, Tao S, Brenner H. MicroRNA signatures: novel biomarkers for colorectal cancer? Cancer Epidemiol Biomarkers Prev 2011;20:1272-86.
9. Michael MZ, O'Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003;1:882-91. (Pubitemid 37288707)
10. Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A, et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 2008;68:5795-802.
11. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. J Am Med Assoc 2008;299:425-36. (Pubitemid 351185951)
12. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, Meijerink WJ, et al. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 2009;101:707-14.
13. Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, Boland CR, et al. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 2010;70:6609-18.
14. Oberg AL, French AJ, Sarver AL, Subramanian S, Morlan BW, Riska SM, et al. miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One 2011;6:e20465.
15. Lanza G, Ferracin M, Gafà R, Veronese A, Spizzo R, Pichiorri F, et al. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 2007;6:54.
16. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, et al. The colorectal microRNAome. Proc Natl Acad Sci U S A 2006;103:3687-92. (Pubitemid 43376616)
17. Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju J. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 2006;12:2014-24.
18. Rossi L, Bonmassar E, Faraoni I. Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacol Res 2007;56:248-53. (Pubitemid 47321208)
19. Akao Y, Nakagawa Y, Naoe T. MicroRNA-143 and -145 in colon cancer. DNA Cell Biol 2007;26:311-20. (Pubitemid 46799180)
20. Akao Y, Nakagawa Y, Naoe T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006;29:903-6.
21. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, et al. Human colon cancer profiles show differential micro-RNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferation states. BMC Cancer 2009;9:401.
22. Earle JS, Luthra R, Romans A, Abraham R, Ensor J, Yao H, et al. Association of microRNA expression with microstatellite instability status in colorectal adenocarcinoma. J Mol Diagn 2010;12:433-40.
23. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
24. Smyth GK. Limma: Linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and computational biology solutions using R and Bioconductor. New York: Springer; 2005. p. 397-420.
25. Pounds S, Morris SW. Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values. Bioinformatics 2003;19:1236-42. (Pubitemid 36850216)
26. Hothorn T, Bretz F, Westfall P. Simultaneous inference in general parametric models. Biom J 2008;50:346-63.
27. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007;6:1586-93. (Pubitemid 47327945)
28. Hol L, Leerdam van M, Boersma AW, Kuipers EJ, Wiemer EA. Micro-RNA expression profiling of colorectal cancer and its precancerous lesions using Lna™ oligonucleotide arrays. Gastroenterology 2008;134:A-748.
29. Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W, Kirchner T. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 1998;194:701-4. (Pubitemid 28523944)
30. Brabletz T, Jung A, Reu S, Porzner M, Hlubek F, Kunz-Schughart LA, et al. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A 2001;98:1036-61.
31. Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, et al. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta-catenin signaling is activated in human colon tumors. Proc Natl Acad Sci U S A 2001;98:14973-8. (Pubitemid 34013954)
32. Nana-Sinkam SP, Croce CM. MicroRNAs as therapeutic targets in cancer. Transl Res 2011;157:216-25.
33. Bader AG, Brown D, Stoudemire J, Lammers P. Developing therapeutic miRNAs for cancer. Gene Ther 2011 Jun 2. [Epub ahead of print].
34. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010;127:118-26.
35. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006.
36. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009;58:1375-81.
37. Brase JC, Wuttig D, Kuner R, Sültmann H. Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 2010;9:306.
38. Dong Y, Wu WK, Wu CW, Sung JJ, Yu J, Ng SS. MicroRNA dysregulation in colorectal cancer: a clinical perspective. Br J Cancer 2011;104:893-8.
39. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci US A 2007;104:15472-7. (Pubitemid 47502941)
40. Borgdorff V, Lleonart ME, Bishop CL, Fessart D, Bergin AH, Overhoff MG, et al. Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1/Cip1). Oncogene 2010;29:2262-71.
41. Takagi K, Sowa Y, Cevik OM, Nakanishi R, Sakai T. CDK inhibitor enhances the sensitivity to 5-fluorouracil in colorectal cancer cells. Int J Oncol 2008;32:1105-10.
42. Niemantsverdriet M, Wagner K, Visser M, Backendorf C. Cellular functions of 14-3-3 zeta in apoptosis and cell adhesion emphasize its oncogenic character. Oncogene 2008;27:1315-9. (Pubitemid 351294692)
43. Jiang Y. Aquaporin-1 activity of plasma membrane affects HT20 colon cancer cell migration. IUBMB Life 2009;61:1001-9.
44. Zou H, Hu L, Li J, Zhan S, Cao K. Cloning and characterization of a novel small monomeric GTPase, RasL10B, with tumor suppressor potential. Biotechnol Lett 2006;28:1901-8. (Pubitemid 44744798)
45. Køadny J, Suchy J, Køujszo-Grabowska E, Kacperski T, Scott RJ, Kurzawski G, et al. Clinical characteristics of tumors derived from colorectal cancer patients who harbor the tumor necrosis factor alpha-1031T/T and NOD2 3020insC polymorphism. Cancer Epidemiol 2009;33:161-3.
46. Deltour S, Pinte S, Guérardel C, Leprince D. Characterization of HRG22, a human homologue of the putative tumor suppressor gene HIC1. Biochem Biophys Res Commun 2001;287:427-34. (Pubitemid 32917616)
47. Fleuriel C, Touka M, Boulay G,Guérardel C, Rood BR, Leprince D. HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors. Int J Biochem Cell Biol 2009;41:26-33.
48. Makos M, Nelkin BD, Lerman MI, Latif F, Zbar B, Baylin SB. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci U S A 1992;89:1929-33.
49. Tsou AP, Chuang YC, Su JY, Yang CW, Liao YL, Liu WK, et al. Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers. J Biomed Sci 2003;10:625-35.
50. Jie X, Lang C, Jian Q, Chaoqun L, Dehua Y, Yi S, et al. Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells. Oncogene 2007;26:5741-51. (Pubitemid 47312814)
51. Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology 2010;138:2059-72.